According to the Foundation Medicine database, the most frequently altered tumor suppressor genes in thymic carcinoma are CDKN2A (39.9%), TP53 (30.2%), and CDKN2B (24.6%) [27], combining deletions and mutations. This evidence concerns the gene CDKN2B and thymic carcinoma.